Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 2.75x is 42% below its estimated 5-year average of 4.77x, near the low end of its estimated 5-year range (2.17x–10.00x).
As of 2026-10-06T15:35:21.230Z. 24.68% below its estimated 12-month average of 3.65x.
Calculation as of: 2026-10-06T15:35:21.230Z.
Quote observation: 2026-10-06T15:35:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ecad0762b01eca72400a5d6f6e26675042e53628e137481382d213c8e973aca5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
2.75x
EV/SALES RATIO AVG TTM
3.65x
EV/SALES RATIO AVG 3Y
3.39x
EV/SALES RATIO AVG 5Y
4.77x
EV/SALES RATIO AVG 10Y
10.07x
EV/SALES RATIO AVG 15Y
46.30x
EV/SALES RATIO AVG 20Y
19.66x
CURRENT VS TTM AVG
-24.68%
CURRENT VS 3Y AVG
-18.94%
CURRENT VS 5Y AVG
-42.36%
CURRENT VS 10Y AVG
-72.68%
CURRENT VS 15Y AVG
-94.06%
CURRENT VS 20Y AVG
-86.01%
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 447 covered companies
CURRENT VS SECTOR MEDIAN
-34.52%
vs the sector median at left
Acadia Pharmaceuticals Inc.
Market Cap
$3.45B
EV/Sales Ratio
2.75x
TTM Avg
3.65x
3Y Avg
3.39x
5Y Avg
4.77x
Market Cap
$3.41B
EV/Sales Ratio
2798.73x
TTM Avg
5544.59x
3Y Avg
5544.59x
5Y Avg
2117.19x
Market Cap
$3.54B
EV/Sales Ratio
4.87x
TTM Avg
6.74x
3Y Avg
6.56x
5Y Avg
7.80x
Market Cap
$3.56B
EV/Sales Ratio
14.19x
TTM Avg
43.04x
3Y Avg
154.35x
5Y Avg
99.29x
Market Cap
$3.13B
EV/Sales Ratio
821.01x
TTM Avg
1123.66x
3Y Avg
904.58x
5Y Avg
368.85x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc. (ACAD) | $3.45B | 2.75x | 3.65x | 3.39x | 4.77x |
| CareDx, Inc (CDNA)vs › | $3.43B | 6.71x | 3.21x | 2.88x | 3.18x |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.41B | N/A | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | 2798.73x | 5544.59x | 5544.59x | 2117.19x |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | 4.87x | 6.74x | 6.56x | 7.80x |
| Celcuity Inc. (CELC)vs › | $3.56B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.56B | 14.19x | 43.04x | 154.35x | 99.29x |
| Denali Therapeutics Inc. (DNLI)vs › | $3.13B | 821.01x | 1123.66x | 904.58x | 368.85x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.09B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 1.20x | 895.62x | 895.62x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 2.78x |
| 2026-10-02 | 2.76x |
| 2026-10-01 | 2.75x |
| 2026-09-30 | 2.79x |
| 2026-09-29 | 2.80x |
| 2026-09-28 | 2.84x |
| 2026-09-25 | 2.87x |
| 2026-09-24 | 3.09x |
| 2026-09-23 | 3.59x |
| 2026-09-22 | 3.74x |
| 2026-09-21 | 3.73x |
| 2026-09-18 | 3.87x |
| 2026-09-17 | 3.89x |
| 2026-09-16 | 3.91x |
| 2026-09-15 | 3.79x |
| 2026-09-14 | 3.90x |
| 2026-09-11 | 3.95x |
| 2026-09-10 | 3.94x |
| 2026-09-09 | 3.93x |
| 2026-09-08 | 3.91x |
| 2026-09-04 | 3.98x |
| 2026-09-03 | 3.96x |
| 2026-09-02 | 4.12x |
| 2026-09-01 | 4.11x |
| 2026-08-31 | 4.12x |
| 2026-08-28 | 4.15x |
| 2026-08-27 | 4.24x |
| 2026-08-26 | 4.22x |
| 2026-08-25 | 4.37x |
| 2026-08-24 | 4.23x |
| 2026-08-21 | 4.20x |
| 2026-08-20 | 4.14x |
| 2026-08-19 | 4.31x |
| 2026-08-18 | 4.31x |
| 2026-08-17 | 4.13x |
| 2026-08-14 | 4.01x |
| 2026-08-13 | 4.03x |
| 2026-08-12 | 4.20x |
| 2026-08-11 | 4.19x |
| 2026-08-10 | 4.19x |
| 2026-08-07 | 4.16x |
| 2026-08-06 | 4.05x |
| 2026-08-05 | 4.10x |
| 2026-08-04 | 4.07x |
| 2026-08-03 | 3.83x |
| 2026-07-31 | 3.87x |
| 2026-07-30 | 3.98x |
| 2026-07-29 | 3.94x |
| 2026-07-28 | 3.89x |
| 2026-07-27 | 3.79x |
| 2026-07-24 | 3.71x |
| 2026-07-23 | 3.70x |
| 2026-07-22 | 3.72x |
| 2026-07-21 | 3.80x |
| 2026-07-20 | 3.75x |
| 2026-07-17 | 3.83x |
| 2026-07-16 | 3.83x |
| 2026-07-15 | 3.88x |
| 2026-07-14 | 3.81x |
| 2026-07-13 | 3.81x |
| 2026-07-10 | 3.92x |
| 2026-07-09 | 3.95x |
| 2026-07-08 | 3.89x |
| 2026-07-07 | 3.92x |
| 2026-07-06 | 3.85x |
| 2026-07-02 | 3.88x |
| 2026-07-01 | 3.76x |
| 2026-06-30 | 3.78x |
| 2026-06-29 | 3.76x |
| 2026-06-26 | 3.78x |
| 2026-06-25 | 3.53x |
| 2026-06-24 | 3.47x |
| 2026-06-23 | 3.35x |
| 2026-06-22 | 3.27x |
| 2026-06-18 | 3.20x |
| 2026-06-17 | 3.19x |
| 2026-06-16 | 3.09x |
| 2026-06-15 | 3.14x |
| 2026-06-12 | 3.11x |
| 2026-06-11 | 3.16x |
| 2026-06-10 | 3.14x |
| 2026-06-09 | 3.23x |
| 2026-06-08 | 3.21x |
| 2026-06-05 | 3.19x |
| 2026-06-04 | 3.21x |
| 2026-06-03 | 3.17x |
| 2026-06-02 | 3.08x |
| 2026-06-01 | 3.18x |
| 2026-05-29 | 3.20x |
| 2026-05-28 | 3.20x |
| 2026-05-27 | 3.13x |
| 2026-05-26 | 3.14x |
| 2026-05-22 | 3.12x |
| 2026-05-21 | 3.15x |
| 2026-05-20 | 3.09x |
| 2026-05-19 | 3.02x |
| 2026-05-18 | 3.05x |
| 2026-05-15 | 3.16x |
| 2026-05-14 | 3.27x |
| 2026-05-13 | 3.29x |
| 2026-05-12 | 3.21x |
| 2026-05-11 | 3.23x |
| 2026-05-08 | 3.32x |
| 2026-05-07 | 3.35x |
| 2026-05-06 | 3.32x |
| 2026-05-05 | 3.46x |
| 2026-05-04 | 3.43x |
| 2026-05-01 | 3.39x |
| 2026-04-30 | 3.47x |
| 2026-04-29 | 3.43x |
| 2026-04-28 | 3.51x |
| 2026-04-27 | 3.45x |
| 2026-04-24 | 3.39x |
| 2026-04-23 | 3.42x |
| 2026-04-22 | 3.44x |
| 2026-04-21 | 3.37x |
| 2026-04-20 | 3.42x |
| 2026-04-17 | 3.43x |
| 2026-04-16 | 3.28x |
| 2026-04-15 | 3.36x |
| 2026-04-14 | 3.40x |
| 2026-04-13 | 3.31x |
| 2026-04-10 | 3.36x |
| 2026-04-09 | 3.49x |
| 2026-04-08 | 3.49x |
| 2026-04-07 | 3.42x |
| 2026-04-06 | 3.45x |
| 2026-04-02 | 3.43x |
| 2026-04-01 | 3.45x |
| 2026-03-31 | 3.44x |
| 2026-03-30 | 3.25x |
| 2026-03-27 | 3.20x |
| 2026-03-26 | 3.32x |
| 2026-03-25 | 3.40x |
| 2026-03-24 | 3.23x |
| 2026-03-23 | 3.24x |
| 2026-03-20 | 3.20x |
| 2026-03-19 | 3.20x |
| 2026-03-18 | 3.13x |
| 2026-03-17 | 3.23x |
| 2026-03-16 | 3.30x |
| 2026-03-13 | 3.18x |
| 2026-03-12 | 3.28x |
| 2026-03-11 | 3.40x |
| 2026-03-10 | 3.49x |
| 2026-03-09 | 3.49x |
| 2026-03-06 | 3.43x |
| 2026-03-05 | 3.47x |
| 2026-03-04 | 3.62x |
| 2026-03-03 | 3.48x |
| 2026-03-02 | 3.53x |
| 2026-02-27 | 3.81x |
| 2026-02-26 | 3.82x |
| 2026-02-25 | 3.88x |
| 2026-02-24 | 3.81x |
| 2026-02-23 | 3.84x |
| 2026-02-20 | 3.72x |
| 2026-02-19 | 3.77x |
| 2026-02-18 | 3.59x |
| 2026-02-17 | 3.55x |
| 2026-02-13 | 3.40x |
| 2026-02-12 | 3.33x |
| 2026-02-11 | 3.47x |
| 2026-02-10 | 3.51x |
| 2026-02-09 | 3.59x |
| 2026-02-06 | 3.65x |
| 2026-02-05 | 3.63x |
| 2026-02-04 | 3.75x |
| 2026-02-03 | 3.84x |
| 2026-02-02 | 4.06x |
| 2026-01-30 | 3.90x |
| 2026-01-29 | 3.99x |
| 2026-01-28 | 3.98x |
| 2026-01-27 | 4.08x |
| 2026-01-26 | 4.18x |
| 2026-01-23 | 4.18x |
| 2026-01-22 | 4.29x |
| 2026-01-21 | 4.17x |
| 2026-01-20 | 4.09x |
| 2026-01-16 | 4.04x |
| 2026-01-15 | 4.13x |
| 2026-01-14 | 4.18x |
| 2026-01-13 | 4.12x |
| 2026-01-12 | 4.14x |
| 2026-01-09 | 4.17x |
| 2026-01-08 | 4.19x |
| 2026-01-07 | 4.27x |
| 2026-01-06 | 4.20x |
| 2026-01-05 | 4.07x |
| 2026-01-02 | 4.09x |
| 2025-12-31 | 4.16x |
| 2025-12-30 | 4.16x |
| 2025-12-29 | 4.25x |
| 2025-12-26 | 4.31x |
| 2025-12-24 | 4.35x |
| 2025-12-23 | 4.34x |
| 2025-12-22 | 4.38x |
| 2025-12-19 | 4.23x |
| 2025-12-18 | 4.14x |
| 2025-12-17 | 4.19x |
| 2025-12-16 | 4.17x |
| 2025-12-15 | 4.25x |
| 2025-12-12 | 4.23x |
| 2025-12-11 | 4.15x |
| 2025-12-10 | 4.18x |
| 2025-12-09 | 4.19x |
| 2025-12-08 | 4.17x |
| 2025-12-05 | 4.28x |
| 2025-12-04 | 4.13x |
| 2025-12-03 | 4.02x |
| 2025-12-02 | 3.95x |
| 2025-12-01 | 3.86x |
| 2025-11-28 | 3.89x |
| 2025-11-26 | 3.85x |
| 2025-11-25 | 3.78x |
| 2025-11-24 | 3.70x |
| 2025-11-21 | 3.65x |
| 2025-11-20 | 3.54x |
| 2025-11-19 | 3.57x |
| 2025-11-18 | 3.68x |
| 2025-11-17 | 3.72x |
| 2025-11-14 | 3.72x |
| 2025-11-13 | 3.66x |
| 2025-11-12 | 3.74x |
| 2025-11-11 | 3.67x |
| 2025-11-10 | 3.42x |
| 2025-11-07 | 3.48x |
| 2025-11-06 | 3.33x |
| 2025-11-05 | 3.50x |
| 2025-11-04 | 3.42x |
| 2025-11-03 | 3.51x |
| 2025-10-31 | 3.56x |
| 2025-10-30 | 3.57x |
| 2025-10-29 | 3.54x |
| 2025-10-28 | 3.55x |
| 2025-10-27 | 3.61x |
| 2025-10-24 | 3.45x |
| 2025-10-23 | 3.40x |
| 2025-10-22 | 3.35x |
| 2025-10-21 | 3.33x |
| 2025-10-20 | 3.27x |
| 2025-10-17 | 3.26x |
| 2025-10-16 | 3.22x |
| 2025-10-15 | 3.41x |
| 2025-10-14 | 3.18x |
| 2025-10-13 | 3.13x |
| 2025-10-10 | 3.13x |
| 2025-10-09 | 3.22x |
| 2025-10-08 | 3.33x |
| 2025-10-07 | 3.37x |
| 2025-10-06 | 3.38x |
| 2025-10-03 | 3.42x |
| 2025-10-02 | 3.35x |
| 2025-10-01 | 3.32x |
| 2025-09-30 | 3.34x |
| 2025-09-29 | 3.34x |
| 2025-09-26 | 3.29x |
| 2025-09-25 | 3.32x |
| 2025-09-24 | 3.33x |
| 2025-09-23 | 3.71x |
Showing the most recent 260 of 4,991 data points. The chart above shows the full history.
